9 research outputs found
CYP2C9 Amino Acid Residues Influencing Phenytoin Turnover and Metabolite Regio- and Stereochemistry
Phenytoin has been an effective anticonvulsant agent for over 60 years,
although its clinical use is complicated by nonlinear pharmacokinetics, a
narrow therapeutic index, and metabolically based drug-drug interactions.
Although it is well established that CYP2C9 is the major cytochrome P450
enzyme controlling metabolic elimination of phenytoin through its oxidative
conversion to (S)-5-(4-hydroxyphenyl)-5-phenylhydantoin
(p-HPPH), nothing is known about the amino acid binding determinants
within the CYP2C9 active site that promote metabolism and maintain the tight
stereocontrol of hydroxy metabolite formation. This knowledge gap was
addressed here through the construction of nine active site mutants at amino
acid positions Phe100, Arg108, Phe114, Leu208, and Phe476 and in vitro
analysis of the steady-state kinetics and stereochemistry of p-HPPH
formation. The F100L and F114W mutants exhibited 4- to 5-fold increases in
catalytic efficiency, whereas the F100W, F114L, F476L, and F476W mutants lost
>90% of their phenytoin hydroxylation capacity. This pattern of effects
differs substantially from that found previously for (S)-warfarin and
(S)-flurbiprofen metabolism, suggesting that these three ligands bind
within discrete locations in the CYP2C9 active site. Only the F114L, F476L,
and L208V mutants altered phenytoin's orientation during catalytic turnover.
The L208V mutant also uniquely demonstrated enhanced 6-hydroxylation of
(S)-warfarin. These latter data provide the first experimental
evidence for a role of the F-G loop region in dictating the catalytic
orientation of substrates within the CYP2C9 active site
Small-Molecule Inhibitors of Cytokine-Mediated STAT1 Signal Transduction In ß-Cells With Improved Aqueous Solubility
We previously reported the discovery of BRD0476 (1), a small molecule generated by diversity-oriented synthesis that suppresses cytokine-induced β-cell apoptosis. Herein, we report the synthesis and biological evaluation of 1 and analogs with improved aqueous solubility. By replacing naphthyl with quinoline moieties, we prepared active analogs with up to a 1400-fold increase in solubility from 1. In addition, we demonstrated that compound 1 and analogs inhibit STAT1 signal transduction induced by IFN-γ
Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases
Coumadin (R-, S-warfarin) is a challenging drug to accurately dose, both initially and for maintenance, because of its narrow therapeutic range and wide interpatient variability and is typically administered as a racemic (Rac) mixture, which complicates the biotransformation pathways. The goal of the current work was to identify the human UDP-glucuronosyltransferases (UGTs) involved in the glucuronidation of the separated R- and S-enantiomers of 6-, 7-, and 8-hydroxywarfarin and the possible interactions between these enantiomers. The kinetic and inhibition constants for human recombinant 1A family UGTs toward these separated enantiomers have been assessed using high-performance liquid chromatography (HPLC)-UV-visible analysis, and product confirmations have been made using HPLC-mass spectrometry/mass spectrometry. We found that separated R- and S-enantiomers of 6-, 7-, and 8-hydroxywarfarin demonstrate significantly different glucuronidation kinetics and can be mutually inhibitory. In some cases significant substrate inhibition was observed, as shown by K(m), V(max), and K(i), comparisons. In particular, UGT1A1 and extrahepatic UGT1A10 have significantly higher capacities than other isoforms for S-7-hydroxywarfarin and R-7-hydroxywarfarin glucuronidation, respectively. Activity data generated using a set of well characterized human liver microsomes supported the recombinant enzyme data, suggesting an important (although not exclusive) role for UGT1A1 in glucuronidation of the main warfarin metabolites, including Rac-6- and 7-hydroxywarfarin and their R- and S-enantiomers in the liver. This is the first demonstration that the R- and S-enantiomers of hydroxywarfarins are glucuronidated, with significantly different enzymatic affinity and capacity, and supports the importance of UGT1A1 as the major hepatic isoform involved
CYP2C9 Genotype-Dependent Effects on in Vitro Drug-Drug Interactions: Switching of Benzbromarone Effect from Inhibition to Activation in the CYP2C9.3 Variant
Small-Molecule Inhibitors of Cytokine-Mediated STAT1 Signal Transduction in β‑Cells with Improved Aqueous Solubility
We
previously reported the discovery of BRD0476 (<b>1</b>), a small
molecule generated by diversity-oriented synthesis that
suppresses cytokine-induced β-cell apoptosis. Herein, we report
the synthesis and biological evaluation of <b>1</b> and analogues
with improved aqueous solubility. By replacing naphthyl with quinoline
moieties, we prepared active analogues with up to a 1400-fold increase
in solubility from <b>1</b>. In addition, we demonstrated that <b>1</b> and analogues inhibit STAT1 signal transduction induced
by IFN-γ
Small-Molecule Inhibitors of Cytokine-Mediated STAT1 Signal Transduction in β-Cells with Improved Aqueous Solubility
Diversifying the genomic data science research community
Over the past 20 years, the explosion of genomic data collection and the cloud computing revolution have made computational and data science research accessible to anyone with a web browser and an internet connection. However, students at institutions with limited resources have received relatively little exposure to curricula or professional development opportunities that lead to careers in genomic data science. To broaden participation in genomics research, the scientific community needs to support these programs in local education and research at underserved institutions (UIs). These include community colleges, historically Black colleges and universities, Hispanic-serving institutions, and tribal colleges and universities that support ethnically, racially, and socioeconomically underrepresented students in the United States. We have formed the Genomic Data Science Community Network to support students, faculty, and their networks to identify opportunities and broaden access to genomic data science. These opportunities include expanding access to infrastructure and data, providing UI faculty development opportunities, strengthening collaborations among faculty, recognizing UI teaching and research excellence, fostering student awareness, developing modular and open-source resources, expanding course-based undergraduate research experiences (CUREs), building curriculum, supporting student professional development and research, and removing financial barriers through funding programs and collaborator support
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Growing evidence suggests that microbes can influence the efficacy of cancer therapies. By studying colon cancer models, we found that bacteria can metabolize the chemotherapeutic drug gemcitabine (2′,2′-difluorodeoxycytidine) into its inactive form, 2′,2′-difluorodeoxyuridine. Metabolism was dependent on the expression of a long isoform of the bacterial enzyme cytidine deaminase (CDD L ), seen primarily in Gammaproteobacteria. In a colon cancer mouse model, gemcitabine resistance was induced by intratumor Gammaproteobacteria, dependent on bacterial CDD L expression, and abrogated by cotreatment with the antibiotic ciprofloxacin. Gemcitabine is commonly used to treat pancreatic ductal adenocarcinoma (PDAC), and we hypothesized that intratumor bacteria might contribute to drug resistance of these tumors. Consistent with this possibility, we found that of the 113 human PDACs that were tested, 86 (76%) were positive for bacteria, mainly Gammaproteobacteria